The Europe Pharmaceutical Gelatin Market would witness market growth of 5.1% CAGR during the forecast period (2022-2028).
To minimize loss of blood during surgery, surgeons use gelatin as it is a widely available hemostatic agent. Gelatin-based hemostats are majorly produced from gelatin derived from porcine collagen (pork skin). These gelatin-based hemostats are used in the form of sponges, strips, powder, or nanofibers.
The high capability of absorption, which is almost forty times their own weight, makes them perfect to be used in creating an artificial blood clot and stemming blood flow. When combined with thrombin, gelatin-based hemostats facilitate the formation of blood clots. Due to their highly biocompatible property, gelatin sponges naturally dissolve when left in the body. Specific dissolution rates are required in some of the Vivo applications in order to configure the gelatin sponges in a specific way to meet the requirements of the individual.
Gelatin is also used in the manufacturing of medical devices such as Femoral plugs, which are the devices used in hip replacements. Gelatin can be used with a plasticizer to make femoral plugs more elastic. They are used in helping the alteration of the prosthesis. When the plaster sets, it secures the tissues from exothermic reactions. It is easier for the body to absorb because of the properties it possesses, such as biocompatibility, low immunogenicity, and more biodegradability.
The National Health Services (NHS), launched in 1948, is the world's most extensive joint healthcare system. It treats around 1 million patients daily. It was created to provide healthcare to all and is free for all UK citizens. NHA shares more than £100 billion in funds to commission health care services in England and holds the organization to oversee the effective spending of these funds. The expanding healthcare sector and the rising funding will surge the usage of medications with gelatin. This factor is anticipated to propel the market growth for pharmaceutical gelatin in the Europe region.
The Germany market dominated the Europe Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $100.3 million by 2028. The UK market is exhibiting a CAGR of 4.2% during (2022 - 2028). Additionally, The France market would experience a CAGR of 5.9% during (2022 - 2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Pharmaceutical Gelatin Market will Hit $1.6 Billion by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
By Type
By Source
By Function
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
